Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
Clinical trial NCT00335179 · COMPLETED
Trial details
- NCT number
- NCT00335179
- Sponsor
- Graceway Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2003-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.